{"transactions":[{"id":1554411,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":92376,"kind":"person","name":"Hakim Nasrat A","position":1,"cik":"0001583742","reported_name":"Hakim Nasrat A","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO, President"}}],"security":"Common Stock","published_at":"2024-04-02T20:58:41.000Z","date":"2024-03-29","kind":"grant","planned":false,"acquired":true,"shares":49534368,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares issued in settlement of compensation owed to the Reporting Person pursuant to his Employment Agreement with the issuer, dated August 1, 2013, as amended."}],"balance_after":216649250,"source":{"system":"sec-edgar","filing":"0001493152-24-012832","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000149315224012832/ownership.xml","form_type":"4"}},{"id":1698149,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":92376,"kind":"person","name":"Hakim Nasrat A","position":1,"cik":"0001583742","reported_name":"Hakim Nasrat A","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO, President"}}],"security":"Common Stock","published_at":"2023-12-29T19:21:28.000Z","date":"2023-12-29","kind":"grant","planned":false,"acquired":true,"shares":2223147,"price":0.069,"value":153397.143,"ownership":{"direct":false,"nature":"Kristine Hakim"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares issued in lieu of cash compensation for Pharmacovigilance and Medical Affairs consulting work during 2018-2022."}],"balance_after":2223147,"source":{"system":"sec-edgar","filing":"0001583742-23-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000158374223000001/primary_doc.xml","form_type":"4"}},{"id":3046749,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":92376,"kind":"person","name":"Hakim Nasrat A","position":1,"cik":"0001583742","reported_name":"Hakim Nasrat A","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO & President"}}],"security":"Series J Convertible Preferred Shares","published_at":"2020-08-26T17:29:58.000Z","date":"2020-08-24","kind":"exercise","acquired":false,"shares":24.0344,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The preferred shares are convertible into shares of common stock at a rate of 6,576,878.18 shares of common stock for each whole share of preferred stock, effectively $0.1521 per share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The preferred shares are convertible into shares of common stock at a rate of 6,576,878.18 shares of common stock for each whole share of preferred stock, effectively $0.1521 per share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shareholder Approval was obtained on June 23, 2020 for an increase in the number of authorized shares of common stock to permit full conversion of the preferred stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"None"}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":158017321},"source":{"system":"sec-edgar","filing":"0001583742-20-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000158374220000002/primary_doc.xml","form_type":"4"}},{"id":3046748,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":92376,"kind":"person","name":"Hakim Nasrat A","position":1,"cik":"0001583742","reported_name":"Hakim Nasrat A","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2020-08-26T17:29:58.000Z","date":"2020-08-24","kind":"exercise","acquired":true,"shares":158017321,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":167114882,"source":{"system":"sec-edgar","filing":"0001583742-20-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000158374220000002/primary_doc.xml","form_type":"4"}},{"id":4335735,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":92376,"kind":"person","name":"Hakim Nasrat A","position":1,"cik":"0001583742","reported_name":"Hakim Nasrat A","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO & President"}}],"security":"Warrants","published_at":"2017-05-03T22:17:58.000Z","date":"2017-04-28","kind":"other","acquired":true,"shares":79008661,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The common shares were returned to the company in exchange for the Series J Convertible Preferred Shares and warrants issued by the company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The date that Shareholder Approval is obtained for an increase in the number of authorized shares of common stock to permit full conversion of the preferred stock and exercise of the warrants."}],"balance_after":79008661,"derivative":{"exercise_price":0.1521,"expiration_date":"2027-04-28","underlying":"Common Stock","underlying_shares":79008661},"source":{"system":"sec-edgar","filing":"0001583742-17-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000158374217000002/primary_doc.xml","form_type":"4"}},{"id":4335734,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":92376,"kind":"person","name":"Hakim Nasrat A","position":1,"cik":"0001583742","reported_name":"Hakim Nasrat A","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO & President"}}],"security":"Series J Convertible Preferred Shares","published_at":"2017-05-03T22:17:58.000Z","date":"2017-04-28","kind":"other","acquired":true,"shares":24.0344,"price":1000000,"value":24034400.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The common shares were returned to the company in exchange for the Series J Convertible Preferred Shares and warrants issued by the company."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The common shares were returned to the company in exchange for the Series J Convertible Preferred Shares and warrants issued by the company."},{"field":"shares","element":"transactionShares","label":"F2","text":"The preferred shares are convertible into shares of common stock at a rate of 6,576,878.18 shares of common stock for each whole share of preferred stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The date that Shareholder Approval is obtained for an increase in the number of authorized shares of common stock to permit full conversion of the preferred stock and exercise of the warrants."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"None."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The preferred shares are convertible into shares of common stock at a rate of 6,576,878.18 shares of common stock for each whole share of preferred stock."}],"balance_after":24.0344,"derivative":{"exercise_price":1000000,"underlying":"Common Stock","underlying_shares":158017321},"source":{"system":"sec-edgar","filing":"0001583742-17-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000158374217000002/primary_doc.xml","form_type":"4"}},{"id":4335733,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":92376,"kind":"person","name":"Hakim Nasrat A","position":1,"cik":"0001583742","reported_name":"Hakim Nasrat A","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2017-05-03T22:17:58.000Z","date":"2017-04-28","kind":"other","acquired":false,"shares":158017321,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The common shares were returned to the company in exchange for the Series J Convertible Preferred Shares and warrants issued by the company."},{"field":"shares","element":"transactionShares","label":"F1","text":"The common shares were returned to the company in exchange for the Series J Convertible Preferred Shares and warrants issued by the company."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The common shares were returned to the company in exchange for the Series J Convertible Preferred Shares and warrants issued by the company."}],"balance_after":9097561,"source":{"system":"sec-edgar","filing":"0001583742-17-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000158374217000002/primary_doc.xml","form_type":"4"}},{"id":4422224,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":92376,"kind":"person","name":"Hakim Nasrat A","position":1,"cik":"0001583742","reported_name":"Hakim Nasrat A","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2017-02-27T23:09:54.000Z","date":"2017-02-23","kind":"grant","acquired":true,"shares":2216992,"price":0.2255,"value":499931.696,"ownership":{"direct":true},"balance_after":24143785,"source":{"system":"sec-edgar","filing":"0001053369-17-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000105336917000001/primary_doc.xml","form_type":"4"}}]}